GTS Securities’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Hold |
0
| – | – | – | 1322 |
|
|
2024
Q3 | – | Sell |
-71,682
| Closed | -$443K | – | 1739 |
|
|
2024
Q2 | $443K | Buy |
71,682
+57,937
| +422% | +$358K | ﹤0.01% | 1012 |
|
|
2024
Q1 | $69.8K | Sell |
13,745
-20,268
| -60% | -$103K | ﹤0.01% | 1291 |
|
|
2023
Q4 | $204K | Buy |
34,013
+10,976
| +48% | +$65.7K | ﹤0.01% | 1322 |
|
|
2023
Q3 | $163K | Buy |
23,037
+4,737
| +26% | +$33.5K | ﹤0.01% | 1191 |
|
|
2023
Q2 | $129K | Buy |
+18,300
| New | +$129K | ﹤0.01% | 1089 |
|